This inventor holds 1 USPTO granted patent. Top assignee: Texas A&M University System. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Daniel T Grunden
Introduction
Daniel T Grunden is an accomplished inventor based in Addison, TX (US). He has made significant contributions to the field of noninvasive glucose monitoring through his innovative patent. His work focuses on improving the efficiency and effectiveness of glucose monitoring systems, which is crucial for individuals managing diabetes.
Latest Patents
Daniel T Grunden holds a patent for "Dual amplitude modulation and polarization frequency modulation as well as compensation for noninvasive glucose monitoring." This invention relates to an improved method and apparatus for modulating the amplitude and rotation of the plane of polarization of linearly polarized light. The primary application of this technology is in noninvasive glucose monitoring systems. Compared to previous monitoring systems, his invention provides faster monitoring while maintaining or even reducing noise and minimizing system complexity. The approach described in his patent addresses these concerns by utilizing a single high-speed device and modulation of the lasers.
Career Highlights
Daniel is affiliated with the Texas A&M University System, where he continues to contribute to research and development in his field. His work has garnered attention for its potential to enhance the quality of life for individuals who rely on glucose monitoring.
Collaborations
Daniel has collaborated with notable colleagues, including Gerard L Cote and Bilal H Malik, who share his commitment to advancing technology in healthcare.
Conclusion
Daniel T Grunden's innovative work in noninvasive glucose monitoring exemplifies the impact of technology on healthcare. His contributions are paving the way for more efficient monitoring systems that can significantly benefit individuals managing diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile